New approach can help design shorter, more powerful trials to assess Parkinson’s drugs


Testing whether a new drug impacts the progression of Parkinson’s disease takes years, in part because the disease often advances so slowly.

Bubonic plague affected human immune system evolution

Previous article

Study illuminates how a typical gut bacterium spreads through the body

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News